Premarin

Known as: Climarest, Climopax 
estrogen supplement drug used to relieve menopausal symptoms
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The use of estrogen-based therapies and the selective estrogen receptor (ER) modulator (SERM), raloxifene, which are approved for… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
CONTEXT Postmenopausal hormone therapy use increased dramatically during the past 2 decades because of a prevailing belief in its… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND AND PURPOSE Estrogen is a known neuroprotective and vasoprotective agent in experimental cerebral ischemia… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To examine the effects of estrogen therapy on cognition, mood, and cerebral blood flow in patients with AD… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND AND PURPOSE We have previously shown that 17beta-estradiol reduces infarction volume in female rats. The present study… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1998
1998
Premarin (Wyeth-Ayerst) is the estrogen replacement treatment of choice and continues to be one of the most widely dispensed… (More)
Is this relevant?
Review
1994
Review
1994
There are numerous literature reports of oral contraceptive-induced (estrogen and progesterone) ischemic bowel disease. However… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Our aim was to define mechanisms whereby conjugated estrogens (Premarin, exogenous estrogen; Ayerst Laboratories, New York… (More)
  • table I
  • figure 1
  • table II
  • figure 2
  • figure 3
Is this relevant?
1982
1982
Dysfunctional uterine bleeding results from disruption of the normal sequence of ovarian cyclic hormonal stimulation of the… (More)
Is this relevant?
Highly Cited
1969
Highly Cited
1969
Sixty-four patients with severe menopausal symptoms completed a four month double-blind placebo trial with conjugated equine… (More)
Is this relevant?